secwatch.observer — SEC 8-K summary
======================================

Issuer:     BXP, Inc. (BXP)
CIK:        0001037540
Form:       8-K
Filed at:   2022-05-02T23:59:59+00:00
Accession:  0001656423-22-000018
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Boston Properties Q1 EPS $0.91 beats guidance; FFO $1.82; acquires Seattle tower for ~$730M
--------------------------------------------------------------------------------

- Q1 revenue $754.3M (+6% YoY); net income $143M ($0.91 EPS) vs $91.6M ($0.59) prior year.
- FFO $1.82/share, exceeding mid-point guidance; driven by portfolio performance and reinstated accrual accounting.
- Executed 1.2M SF of leases in Q1 (double YoY); including 330K SF renewal at 601 Lexington Ave, NY.
- Agreed to acquire Madison Centre in Seattle for ~$730M; signed 570K SF lease with AstraZeneca in Cambridge, MA.
- FY 2022 guidance: EPS $5.32-$5.42; FFO $7.40-$7.50; Q2 EPS $0.79-$0.81; FFO $1.84-$1.86.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/0001656423-22-000018-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1037540/000165642322000018/bxp-20220502.htm
  HTML page:      https://secwatch.observer/filing/0001656423-22-000018

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer